Diagnostic impact of postoperative CA19-9 dynamics on pancreatic cancer recurrence : a single-institution retrospective study
© 2024. Italian Society of Surgery (SIC)..
Postoperative CA19-9 elevation after pancreatic cancer resection suggests recurrence but can also occur in benign conditions. This study aimed to investigate the interpretation of postoperative CA19-9 elevation after pancreatic cancer surgery in terms of cancer recurrence. A cohort of patients undergoing pancreatectomy for pancreatic cancer at our hospital was included. Among them, 52 patients exhibited postoperative CA19-9 elevation without radiological evidence of recurrence. These patients were evaluated with follow-up CA19-9 measurements. The CA19-9 increase rates were calculated based on the first elevation and the follow-up measurement. The association between the CA19-9 increase rate and tumor recurrence was assessed. Patients with a CA19-9 increase rate of ≥ 30% had a significantly higher frequency of recurrence within 3 months compared to those without such an increase (p = 0.0002). Multivariate analysis demonstrated that a CA19-9 increase rate of ≥ 30% was an independent risk factor for recurrence (odds ratio 8.17, p = 0.0309). The CA19-9 value at the first elevation (p = 0.1794) and at the follow-up measurement (p = 0.1121) were not associated with recurrence. After the first postoperative CA19-9 elevation, the CA19-9 increase rate based on follow-up measurements can serve as a predictive factor for tumor recurrence.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:76 |
---|---|
Enthalten in: |
Updates in surgery - 76(2024), 2 vom: 01. Apr., Seite 479-486 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Imamura, Hiroki [VerfasserIn] |
---|
Links: |
---|
Themen: |
Biomarkers, Tumor |
---|
Anmerkungen: |
Date Completed 05.04.2024 Date Revised 05.04.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s13304-024-01758-x |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM368396967 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM368396967 | ||
003 | DE-627 | ||
005 | 20240405233539.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240213s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s13304-024-01758-x |2 doi | |
028 | 5 | 2 | |a pubmed24n1366.xml |
035 | |a (DE-627)NLM368396967 | ||
035 | |a (NLM)38349569 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Imamura, Hiroki |e verfasserin |4 aut | |
245 | 1 | 0 | |a Diagnostic impact of postoperative CA19-9 dynamics on pancreatic cancer recurrence |b a single-institution retrospective study |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 05.04.2024 | ||
500 | |a Date Revised 05.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2024. Italian Society of Surgery (SIC). | ||
520 | |a Postoperative CA19-9 elevation after pancreatic cancer resection suggests recurrence but can also occur in benign conditions. This study aimed to investigate the interpretation of postoperative CA19-9 elevation after pancreatic cancer surgery in terms of cancer recurrence. A cohort of patients undergoing pancreatectomy for pancreatic cancer at our hospital was included. Among them, 52 patients exhibited postoperative CA19-9 elevation without radiological evidence of recurrence. These patients were evaluated with follow-up CA19-9 measurements. The CA19-9 increase rates were calculated based on the first elevation and the follow-up measurement. The association between the CA19-9 increase rate and tumor recurrence was assessed. Patients with a CA19-9 increase rate of ≥ 30% had a significantly higher frequency of recurrence within 3 months compared to those without such an increase (p = 0.0002). Multivariate analysis demonstrated that a CA19-9 increase rate of ≥ 30% was an independent risk factor for recurrence (odds ratio 8.17, p = 0.0309). The CA19-9 value at the first elevation (p = 0.1794) and at the follow-up measurement (p = 0.1121) were not associated with recurrence. After the first postoperative CA19-9 elevation, the CA19-9 increase rate based on follow-up measurements can serve as a predictive factor for tumor recurrence | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a CA19-9 | |
650 | 4 | |a Dynamics | |
650 | 4 | |a Pancreatic cancer | |
650 | 4 | |a Postoperative follow-up | |
650 | 4 | |a Recurrence | |
650 | 7 | |a CA-19-9 Antigen |2 NLM | |
650 | 7 | |a Biomarkers, Tumor |2 NLM | |
700 | 1 | |a Tomimaru, Yoshito |e verfasserin |4 aut | |
700 | 1 | |a Kobayashi, Shogo |e verfasserin |4 aut | |
700 | 1 | |a Yamada, Daisaku |e verfasserin |4 aut | |
700 | 1 | |a Noda, Takehiro |e verfasserin |4 aut | |
700 | 1 | |a Takahashi, Hidenori |e verfasserin |4 aut | |
700 | 1 | |a Doki, Yuichiro |e verfasserin |4 aut | |
700 | 1 | |a Eguchi, Hidetoshi |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Updates in surgery |d 2010 |g 76(2024), 2 vom: 01. Apr., Seite 479-486 |w (DE-627)NLM201602180 |x 2038-3312 |7 nnns |
773 | 1 | 8 | |g volume:76 |g year:2024 |g number:2 |g day:01 |g month:04 |g pages:479-486 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s13304-024-01758-x |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 76 |j 2024 |e 2 |b 01 |c 04 |h 479-486 |